Table 1 Clinicopathological and prognostic characteristics of epithelioid and spindle rhabdomyosarcoma
Study | Age (Y)/Sex | Size (cm) | Location | Rec/Met | Treatment | Follow-up (Mon) | Outcome |
|---|---|---|---|---|---|---|---|
Dashti/2018 | 70–75/M | 4 | Mandible | No | No | 2 | AWND |
Wong/2019 | 20–25/M | 8 | Nasal cavity | No | Exc, CR | 4 | DD |
Agaram/2019 | 25–30/F | NA | Skull | NA | NA | NA | NA |
Agaram/2019 | 30–35/F | NA | Maxilla | NA | NA | NA | NA |
Agaram/2019 | 20–25/M | NA | Femur | No | Exc | 108 | AWND |
Agaram/2019 | 35–40/F | NA | Iliac | NA | NA | NA | NA |
Agaram/2019 | 20–25/F | NA | Femur | L | NA | 30 | AWD |
Tagami/2019 | 70–75/F | Biopsy | Ver | No | CR | 6 | AWD |
Zhu/2019 | 70–75/F | 4 | Maxillary gingiva | NA | NA | NA | NA |
Le Loarer/2019 | 15–20/F | 9 | Sphenoid | No | Exc, CR | 15 | DD |
Le Loarer/2019 | 25–30/F | 10 | Sacrum | L, Med, LN | Ch | 4 | DD |
Le Loarer/2019 | 35–40/F | NA | Peritoneum | No | Ch | 2 | DD |
Le Loarer/2019 | 30–35/M | NA | Hard palate & upper lip | Ver & ribs & pelvis | Ch | 8 | DD |
Le Loarer/2019 | 20–25/M | 15 | Orbito & temporal & sphenoid | LP | CR | 6 | DD |
Le Loarer/2019 | 85–90/M | 6.5 | Inguinal | LP | Exc | 6 | DD |
Le Loarer/2019 | 15–20/F | 5.1 | Femur | LP | Exc, Ch | 8 | DD |
Le Loarer/2019 | 15–20/F | 5.3 | Cervico-occipital | LP | Exc, Ch | 15 | AWD |
Le Loarer/2019 | 30–35/M | 11.8 | Left occipital | L, Med | Exc, Ch | 6 | DD |
Le Loarer/2019 | 30–35/M | 4.5 | Mandible | L | Exc, Ch | 14 | AWD |
Le Loarer/2019 | 55–60/F | 1.6 | Mandible | No | Exc, CR | 21 | AWND |
Le Loarer/2019 | 10–15/F | 5.5 | Mandible | No | Exc, CR | 21 | AWND |
Le Loarer/2019 | 10–15/F | NA | Maxilla | NA | NA | NA | DD |
Le Loarer/2019 | 25–30/M | 3.4 | Mandible | No | Exc, Ch | 20 | AWND |
Chrisinger/2020 | 20–30/F | 5 | Frontal bone | L | Exc, CR | 17 | DD |
Chrisinger/2020 | 20–25/F | 13.6 | Pelvic bones | L, Ver | CR | 11 | DD |
Xu/2021 | 20–25/M | NA | Mandible | LN | NA | NA | NA |
Xu/2021 | 30–35/M | NA | Mandible | No | NA | 10 | AWD |
Xu/2021 | 15–20/M | NA | Mandible | L, Bone, LN | Exc, CR | 20 | DD |
Xu/2021 | 40–45/F | NA | Mandible | NA | NA | NA | NA |
Xu/2021 | 15–20/M | NA | Skull | NA | NA | NA | NA |
Xu/2021 | 25–30/M | NA | Skull | L | NA | 2 | AWD |
Xu/2021 | 40–45/F | NA | Neck | NA | NA | NA | NA |
Our case | 30–35/F | 5 | Abdominal wall | Med | Exc, TCM | 24 | AWD |